Artelo Biosciences (ARTL) Payables (2015 - 2025)
Artelo Biosciences (ARTL) posted quarterly Payables of $3.5 million for Q4 2025, up 107.16% year-over-year from $1.7 million in Q4 2024, and down 26.8% quarter-over-quarter from $4.7 million in Q3 2025.
Artelo Biosciences (ARTL) Payables (2015 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Payables for 11 consecutive years, with $3.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables rose 107.16% year-over-year to $3.5 million; the TTM figure through Dec 2025 stood at $3.5 million (up 107.16% YoY), while the FY2025 annual figure was $3.5 million, up 107.16% from the prior year.
- Payables declined to $3.5 million in Q4 2025 per ARTL's latest filing, from $4.7 million in the prior quarter.
- Across five years, Payables topped out at $4.8 million in Q2 2025 and bottomed at $411000.0 in Q3 2022.
- Historically, Payables has averaged $1.5 million across 5 years, with a median of $820000.0 in 2022.
- Annual changes were most pronounced in 2024 — Payables decreased 25.36% — and 2025, when it surged 656.46%.
- Artelo Biosciences' Payables stood at $590000.0 in 2021, then jumped by 53.39% to $905000.0 in 2022, then soared by 36.8% to $1.2 million in 2023, then jumped by 35.38% to $1.7 million in 2024, then soared by 107.16% to $3.5 million in 2025.
- Business Quant data shows ARTL's Payables at $3.5 million in Q4 2025, $4.7 million in Q3 2025, and $4.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - | 3.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Jun 30, 2025 | 4.84 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 627,000.00 |
| Jun 30, 2024 | 863,000.00 |
| Mar 31, 2024 | 607,000.00 |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 840,000.00 |
| Jun 30, 2023 | 523,000.00 |
| Mar 31, 2023 | 701,000.00 |
| Dec 31, 2022 | 905,000.00 |
| Sep 30, 2022 | 411,000.00 |
| Jun 30, 2022 | 432,000.00 |
| Mar 31, 2022 | 800,000.00 |
| Nov 30, 2021 | 590,000.00 |
| Aug 31, 2021 | 471,000.00 |
| Aug 31, 2020 | 489,000.00 |
| Aug 31, 2019 | 29.85 Mn |